RT @UMassMedRTI: Anastasia Khvorova discussing potential treatments for #preeclampsia and how to make the path easier to develop drugs for…
Anastasia Khvorova discussing potential treatments for #preeclampsia and how to make the path easier to develop drugs for pregnant women #RNATx2019 https://t.co/I9h8suEXto
RT @HarrisVitiligo: Cool commentary about work done by my UMass colleague Dr. Anastasia Khvorova. Very exciting data! https://t.co/l5GIaFhR…
Cool commentary about work done by my UMass colleague Dr. Anastasia Khvorova. Very exciting data! https://t.co/l5GIaFhRNB
RT @srah62: @Beyonce!! Just watched your Homecoming documentary and learned that you had Preeclampsia. The #khvorovalab is developing a dru…
RT @UMassMedRTI: We made @statnews madness X 2! The RTI's Anastasia Khvorova & Melissa Moore with their preeclampsia study: https://t.co/bY…
RT @UMassMedRTI: We made @statnews madness X 2! The RTI's Anastasia Khvorova & Melissa Moore with their preeclampsia study: https://t.co/bY…
RT @UMassMedRTI: We made @statnews madness X 2! The RTI's Anastasia Khvorova & Melissa Moore with their preeclampsia study: https://t.co/bY…
RT @UMassMedRTI: We made @statnews madness X 2! The RTI's Anastasia Khvorova & Melissa Moore with their preeclampsia study: https://t.co/bY…
We made @statnews madness X 2! The RTI's Anastasia Khvorova & Melissa Moore with their preeclampsia study: https://t.co/bYzJqhcU8J and @muellerlab's ALS study: https://t.co/dlb8KBnWZ4 Voting opens March 4!! VOTE @UMassMedical https://t.co/iFQnlOz9Bw
Stunning preclinical work on a RNAi-based treatment of pre-eclampsia in a baboon model, "a single dose of siRNAs suppressed sFLT1 overexpression and clinical signs of preeclampsia" https://t.co/k2sxTtVtEa #pathology https://t.co/Lxe8MPHdm7
Excellent translational work from @ananthmsn34, Moore, and Khvorova propelling the anti-angiogenic paradigm for pre-ecclampsia, applying cholesterol-conjugated placental sFLT1 isoform-specific siRNA in mice & baboons with impressive results. https://t
The spotlighted paper: https://t.co/5YGNBKQD1X
RT @OTSociety: Taming preeclampsia at its source https://t.co/n1bUaKp2Fr a highlight of "RNAi modulation of placental sFLT1 for the tr…
RT @OTSociety: Taming preeclampsia at its source https://t.co/n1bUaKp2Fr a highlight of "RNAi modulation of placental sFLT1 for the tr…
Taming preeclampsia at its source https://t.co/n1bUaKp2Fr a highlight of "RNAi modulation of placental sFLT1 for the treatment of preeclampsia" https://t.co/aFvbvhCxgZ https://t.co/PHL5JYamNU
RT @SimonWad: siRNA for preeclampsia https://t.co/K8ho5m6LWb @drdmacintyre @PrenatalTherapy @DrNLK0
RT @SimonWad: siRNA for preeclampsia https://t.co/K8ho5m6LWb @drdmacintyre @PrenatalTherapy @DrNLK0
RT @SimonWad: siRNA for preeclampsia https://t.co/K8ho5m6LWb @drdmacintyre @PrenatalTherapy @DrNLK0
siRNA for preeclampsia https://t.co/K8ho5m6LWb @drdmacintyre @PrenatalTherapy @DrNLK0
@battagliame30 @statnews Serious? Get a Nature subscription to garner any serious considerations. https://t.co/VFCigYm9EM
RT @NatureBiotech: #RNAi modulation of placental sFLT1 for the treatment of #preeclampsia https://t.co/BiWeQM17uH https://t.co/G36jHokcS7
RT @AntonTuranov: Our study - siRNA-based therapeutics for the treatment of preeclampsia is in Nature Biotechnology today. #medicine #bio…
RNAi modulation of placental sFLT1 for the treatment of preeclampsia $ARWR $DRNA $ALNY $ABUS $RXII $SLN #siRNA #RNAi @RNAi_papers @mooreorless62 https://t.co/XWlHu8czIc https://t.co/9JdeP6b4SM
RT @794Shinpei: siRNA injectionによる妊娠高血圧腎症の治療。Single shotで胎盤で発現する原因遺伝子sFlt1を最大50%抑制できるということ。モデルとして検証しているのはなんとマントヒヒ。 https://t.co/iSqlfgE7eO
RT @794Shinpei: siRNA injectionによる妊娠高血圧腎症の治療。Single shotで胎盤で発現する原因遺伝子sFlt1を最大50%抑制できるということ。モデルとして検証しているのはなんとマントヒヒ。 https://t.co/iSqlfgE7eO
siRNA injectionによる妊娠高血圧腎症の治療。Single shotで胎盤で発現する原因遺伝子sFlt1を最大50%抑制できるということ。モデルとして検証しているのはなんとマントヒヒ。 https://t.co/iSqlfgE7eO
RT @UMassMedRTI: . @WorcNewsTonight interviewing the RTI’s Anastasia Khvorova & Melissa Moore on their recent work on #RNAi development for…
RT @UMassMedRTI: . @WorcNewsTonight interviewing the RTI’s Anastasia Khvorova & Melissa Moore on their recent work on #RNAi development for…
. @WorcNewsTonight interviewing the RTI’s Anastasia Khvorova & Melissa Moore on their recent work on #RNAi development for the treatment of #preeclampsia Tune in tonight for the full interview! https://t.co/bYzJqhcU8J https://t.co/g9e3LVIBOj
Anti-anti-angiogenesis for pre-eclampsia? Pretty cool modulation of the VEGF pathway. https://t.co/vTLB2vd5rY
RT @MinnowWalsh: RNAi modulation of placental sFLT1 for the treatment of preeclampsia. In a baboon model, a single dose of siRNAs suppresse…
RT @MinnowWalsh: RNAi modulation of placental sFLT1 for the treatment of preeclampsia. In a baboon model, a single dose of siRNAs suppresse…
RNAi modulation of placental sFLT1 for the treatment of preeclampsia | Nature Biotechnology https://t.co/lrTWz3kKxD
RT @MinnowWalsh: RNAi modulation of placental sFLT1 for the treatment of preeclampsia. In a baboon model, a single dose of siRNAs suppresse…
RNAi modulation of placental sFLT1 for the treatment of preeclampsia. In a baboon model, a single dose of siRNAs suppressed sFLT1 overexpression and clinical signs of preeclampsia. https://t.co/sXPizRfrMc #CardioObstetrics @NatureBiotech @TheObGProject
RT @ScienceinBoston: In a collaborative effort to improve maternal and fetal health, a team including @AntonTuranov and @mooreorless62 from…
RT @ScienceinBoston: In a collaborative effort to improve maternal and fetal health, a team including @AntonTuranov and @mooreorless62 from…
RT @ScienceinBoston: In a collaborative effort to improve maternal and fetal health, a team including @AntonTuranov and @mooreorless62 from…
In a collaborative effort to improve maternal and fetal health, a team including @AntonTuranov and @mooreorless62 from @UMassMedRTI used siRNAs to suppress the synthesis of placental sFLT1 proteins that are responsible for #preeclampsia. https://t.co/Nfecn
This is the way cancer diseases don’t like. #RNAinterference is a great approach to anticipate disease’s onset and evolution. Formidable results have also been obtained with certain solid tumor forms in a elegant and selective way. #GenomeEditing... https:
RT @AntonTuranov: Our study - siRNA-based therapeutics for the treatment of preeclampsia is in Nature Biotechnology today. #medicine #bio…
RNAi-based therapy for silencing preeclampsia-causing gene in mouse and baboon model systems #RNA #nucleicacidtherapy https://t.co/k7vhT3WQgJ
#RNAi で #プレ子癇症 を治療?有効にsFLT1を黙らせられる、と(バブーン):U Mass。 https://t.co/epdRLsJUC6
RNAi modulation of placental sFLT1 for the treatment of preeclampsia | Nature Biotechnology https://t.co/lrTWz3kKxD
RT @calibre_medical: insightful, thanks https://t.co/Mkn3sp0ji8
insightful, thanks
RT @NatureBiotech: #RNAi modulation of placental sFLT1 for the treatment of #preeclampsia https://t.co/BiWeQM17uH https://t.co/G36jHokcS7
incredible work showing promise of #RNAi therapy for extrahepatic tissues using a baboon #preeclampsia model from @UMassMedRTI
#RNAi #modulation of placental #sFLT1 for the #treatment of #preeclampsia..https://t.co/Uzm7Kkov4v
RT @biopharmQDa: Congrats! Great to see the potential of #RNAi coming to fruition in dramatic ways. Nice Work! https://t.co/avE8V64K3Q
RNAi modulation of placental sFLT1 for the treatment of preeclampsia. https://t.co/LcXjl6v0o9
"RNAi modulation of placental sFLT1 for the treatment of preeclampsia" https://t.co/bfJeunCgLJ
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
Top story! RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia https://t.co/XuTYdaEVxX
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @AndyBiotech: RNAi therapy mitigates #preeclampsia symptoms https://t.co/cBu2Ma2vWB Targeting placental sFLT1 isoforms https://t.co/uNd…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
@gbrc_dst
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @AndyBiotech: RNAi therapy mitigates #preeclampsia symptoms https://t.co/cBu2Ma2vWB Targeting placental sFLT1 isoforms https://t.co/uNd…
RT @NatureBiotech: #RNAi modulation of placental sFLT1 for the treatment of #preeclampsia https://t.co/BiWeQM17uH https://t.co/G36jHokcS7
RT @bmcruzgod: Well done to our @AntonTuranov and to our lab with some impressive breakthroughs on RNAi for Preeclampsia! @UMassMedRTI ht…
RT @AntonTuranov: Our study - siRNA-based therapeutics for the treatment of preeclampsia is in Nature Biotechnology today. #medicine #bio…
RT @NatureBiotech: #RNAi modulation of placental sFLT1 for the treatment of #preeclampsia https://t.co/BiWeQM17uH https://t.co/G36jHokcS7
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @AntonTuranov: Our study - siRNA-based therapeutics for the treatment of preeclampsia is in Nature Biotechnology today. #medicine #bio…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
Yeah!!! Congrats Anton and the Khvorova lab!
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @AntonTuranov: Our study - siRNA-based therapeutics for the treatment of preeclampsia is in Nature Biotechnology today. #medicine #bio…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @NatureBiotech: #RNAi modulation of placental sFLT1 for the treatment of #preeclampsia https://t.co/BiWeQM17uH https://t.co/G36jHokcS7
RT @AntonTuranov: Our study - siRNA-based therapeutics for the treatment of preeclampsia is in Nature Biotechnology today. #medicine #bio…
RT @NatureBiotech: #RNAi modulation of placental sFLT1 for the treatment of #preeclampsia https://t.co/BiWeQM17uH https://t.co/G36jHokcS7
RT @AntonTuranov: Our study - siRNA-based therapeutics for the treatment of preeclampsia is in Nature Biotechnology today. #medicine #bio…
RT @NatureBiotech: #RNAi modulation of placental sFLT1 for the treatment of #preeclampsia https://t.co/BiWeQM17uH https://t.co/G36jHokcS7
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
Congrats! Great to see the potential of #RNAi coming to fruition in dramatic ways. Nice Work!
RT @AndyBiotech: RNAi therapy mitigates #preeclampsia symptoms https://t.co/cBu2Ma2vWB Targeting placental sFLT1 isoforms https://t.co/uNd…
RT @NatureBiotech: #RNAi modulation of placental sFLT1 for the treatment of #preeclampsia https://t.co/BiWeQM17uH https://t.co/G36jHokcS7
Very proud for @AntonTuranov and his siRNA-based therapy for preeclamsia. In the age of CRISPR siRNA is still a very effective approach.
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @AntonTuranov: Our study - siRNA-based therapeutics for the treatment of preeclampsia is in Nature Biotechnology today. #medicine #bio…
RNAi modulation of placental sFLT1 for the treatment of preeclampsia https://t.co/x1rWpVfZN1 https://t.co/4edG1gS8Ew
RT @bmcruzgod: Well done to our @AntonTuranov and to our lab with some impressive breakthroughs on RNAi for Preeclampsia! @UMassMedRTI ht…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @NatureBiotech: #RNAi modulation of placental sFLT1 for the treatment of #preeclampsia https://t.co/BiWeQM17uH https://t.co/G36jHokcS7
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @bmcruzgod: Well done to our @AntonTuranov and to our lab with some impressive breakthroughs on RNAi for Preeclampsia! @UMassMedRTI ht…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…
RT @UMassMedRTI: Extremely excited (and proud) to share this paper @NatureBiotech from the Khvorova & Moore labs, @AntonTuranov, on a game…